The role of microvesicles in tissue repair
暂无分享,去创建一个
G. Camussi | M. Deregibus | V. Fonsato | C. Tetta | S. Bruno
[1] G. Camussi,et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] N. Ohkohchi,et al. Platelet Administration Via the Portal Vein Promotes Liver Regeneration in Rats After 70% Hepatectomy , 2011, Annals of surgery.
[3] D. Miao,et al. Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse , 2011, PloS one.
[4] N. Perico,et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[5] Li Yan,et al. The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. , 2010, Cytotherapy.
[6] Matthew K. Knabel,et al. Stem Cell Mobilization Is Life Saving in an Animal Model of Acute Liver Failure , 2010, Annals of surgery.
[7] Luca Sterpone,et al. Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs , 2010, PloS one.
[8] P. Thorner,et al. Angiomyeloproliferative lesions following autologous stem cell therapy. , 2010, Journal of the American Society of Nephrology : JASN.
[9] P. Quesenberry,et al. Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. , 2010, Experimental hematology.
[10] Liyong Pu,et al. Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats. , 2010, Stem cells and development.
[11] C M Habibullah,et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. , 2010, Cell transplantation.
[12] G. Camussi,et al. The dynamic stem cell microenvironment is orchestrated by microvesicle-mediated transfer of genetic information. , 2010, Histology and histopathology.
[13] G. Camussi,et al. Use of a rotary bioartificial liver in the differentiation of human liver stem cells. , 2010, Tissue engineering. Part C, Methods.
[14] G. Camussi,et al. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information , 2010, Current opinion in nephrology and hypertension.
[15] M. Shimizu,et al. Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney Model , 2009, Stem cells.
[16] D. Neuberg,et al. Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy , 2009, Clinical Cancer Research.
[17] G. Camussi,et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats , 2009, Journal of cellular and molecular medicine.
[18] Alessandro Busca,et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.
[19] A. Cohen,et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. , 2009, Stem cells and development.
[20] Jinkuk Kim,et al. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. , 2009, Stem cells and development.
[21] W. Weimar,et al. Potential of mesenchymal stem cells as immune therapy in solid‐organ transplantation , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[22] D. Farber,et al. Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles , 2009, PloS one.
[23] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[24] A. Falus,et al. Highlights of a new type of intercellular communication: microvesicle-based information transfer , 2009, Inflammation Research.
[25] J. Ryan,et al. Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non‐redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells , 2008, Clinical and experimental immunology.
[26] N. Perico,et al. Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1 , 2008, The Journal of Immunology.
[27] N. Perico,et al. Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice , 2008, Stem cells.
[28] P. Veys,et al. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. , 2008, Blood.
[29] P. Quesenberry,et al. The Paradoxical Dynamism of Marrow Stem Cells: Considerations of Stem Cells, Niches, and Microvesicles , 2008, Stem Cell Reviews.
[30] M. Yarmush,et al. Mesenchymal stem cell–derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo , 2008, Hepatology.
[31] I. Sargent,et al. Microparticles and immunomodulation in pregnancy and pre-eclampsia. , 2007, Journal of reproductive immunology.
[32] G. Remuzzi,et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. , 2007, Journal of the American Society of Nephrology : JASN.
[33] L. Noel,et al. Intra Renal Arterial Injection of Autologous Mesenchymal Stem Cells in an Ovine Model in the Postischemic Kidney , 2007, Nephron Physiology.
[34] Luigi Biancone,et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. , 2007, Blood.
[35] M. Yarmush,et al. Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic Failure , 2007, PloS one.
[36] L. Cantley,et al. Stromal cells protect against acute tubular injury via an endocrine effect. , 2007, Journal of the American Society of Nephrology : JASN.
[37] I. Stamenkovic,et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. , 2007, Kidney international.
[38] D. Pisetsky,et al. The Role of Microparticles in Inflammation and Thrombosis , 2007, Scandinavian journal of immunology.
[39] P. Boor,et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. , 2007, Journal of the American Society of Nephrology : JASN.
[40] Florian Tögel,et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. , 2007, American journal of physiology. Renal physiology.
[41] G. Parmiani,et al. Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.
[42] P. M. Wang,et al. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. , 2007, Transplantation proceedings.
[43] G. Camussi,et al. Isolation and Characterization of a Stem Cell Population from Adult Human Liver , 2006, Stem cells.
[44] J Ratajczak,et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.
[45] H. Anders,et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. , 2006, Kidney international.
[46] A. Levine,et al. The regulation of exosome secretion: a novel function of the p53 protein. , 2006, Cancer research.
[47] J Ratajczak,et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.
[48] G. Camussi,et al. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. , 2006, Cytokine.
[49] G. Garcia-Manero,et al. The Cyclin-Dependent Kinase Inhibitor p57KIP2 Functions as a Tumor Suppressor Gene in Human Leukemia. , 2005 .
[50] J. Duffield,et al. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. , 2005, Kidney international.
[51] R. Schein,et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis , 2005, Critical care medicine.
[52] A. Zander,et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. , 2005, Kidney international.
[53] José A López,et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.
[54] L. Hsiao,et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. , 2005, The Journal of clinical investigation.
[55] N. Caplice,et al. Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. , 2005, Stem cells and development.
[56] Bing Li,et al. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. , 2005, Kidney international.
[57] C. Lange,et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. , 2005, American journal of physiology. Renal physiology.
[58] J. Freyssinet,et al. Membrane microparticles: two sides of the coin. , 2005, Physiology.
[59] G. Camussi,et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. , 2004, International journal of molecular medicine.
[60] G. Camussi,et al. Role of L-Selectin in the Vascular Homing of Peripheral Blood-Derived Endothelial Progenitor Cells1 , 2004, The Journal of Immunology.
[61] M. Goligorsky,et al. Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia. , 2004, American journal of physiology. Renal physiology.
[62] T. Rabelink,et al. Progenitor cells in the kidney: biology and therapeutic perspectives. , 2004, Kidney international.
[63] Geoffrey C Gurtner,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.
[64] N. Perico,et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. , 2004, Journal of the American Society of Nephrology : JASN.
[65] T. Shimazu,et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. , 2004, The Journal of trauma.
[66] M. Krampera,et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.
[67] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[68] F. Kajiya,et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. , 2002, American journal of physiology. Renal physiology.
[69] J. Cavaillon,et al. Long‐term‐impaired expression of nuclear factor‐κB and IκBα in peripheral blood mononuclear cells of trauma patients , 2001, Journal of Leukocyte Biology.
[70] J. Cavaillon,et al. Interleukin-1 receptor antagonist production during infectious and noninfectious systemic inflammatory response syndrome , 2000, Critical care medicine.
[71] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[72] K. Asadullah,et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis , 1996, Intensive Care Medicine.
[73] L. Shapiro,et al. Ciliary Neurotrophic Factor Combined with Soluble Receptor Inhibits Synthesis of Proinflammatory Cytokines and Prostaglandin-E2in Vitro , 1994 .
[74] J. Mier,et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. , 1993, Journal of immunology.
[75] J. Cavaillon,et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.
[76] J. Kovacs,et al. The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.
[77] A. Leaf. Cell Swelling: A Factor in Ischemic Tissue Injury , 1973, Circulation.
[78] P. Siekevitz. Biological membranes: the dynamics of their organization. , 1972, Annual Review of Physiology.
[79] R. Malekzadeh,et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. , 2011, Archives of Iranian medicine.
[80] Ciro Tetta,et al. Exosome/microvesicle-mediated epigenetic reprogramming of cells. , 2011, American journal of cancer research.
[81] Baharvand Hossein,et al. AUTOLOGOUS TRANSPLANTATION OF BONE MARROW-DERIVED MONONUCLEAR AND CD133+ CELLS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS , 2011 .
[82] Krisztián Németh,et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.
[83] H. K. Kim,et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.
[84] J. Cavaillon,et al. Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. , 2001, Journal of leukocyte biology.
[85] J J Sixma,et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. , 1999, Blood.
[86] L. Shapiro,et al. Ciliary neurotrophic factor combined with soluble receptor inhibits synthesis of proinflammatory cytokines and prostaglandin-E2 in vitro. , 1994, Experimental cell research.
[87] A. Leaf,et al. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. , 1972, The Journal of clinical investigation.